Mega Lifesciences


Concise Prescribing Info
Clopidogrel bisulphate
Reduction of atherothrombotic events in patients w/ recent MI, recent stroke or established peripheral arterial disease; acute coronary syndrome.
Dosage/Direction for Use
Recent MI, recent stroke or established peripheral arterial disease 75 mg once daily. Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q wave MI) Initially 300 mg loading dose & then continued at 75 mg once daily. ST-segment elevation acute MI 75 mg once daily in combination w/ aspirin w/ or w/o thrombolytics.
May be taken with or without food.
Hypersensitivity. Active pathological bleeding eg peptic ulcer or intracranial hemorrhage.
Special Precautions
Impaired CYP2C19 function. Patients at risk of increased bleeding from trauma, surgery or other pathological conditions. Discontinue 5 days prior to surgery. Perform blood cell count determinations. Lesions w/ a propensity to bleed. Severe hepatic & renal impairment. Pregnancy & lactation. Childn.
Adverse Reactions
Chest pain, accidental/inflicted injury, flu-like symptoms, pain, fatigue. Asthenia, fever, hernia. Edema, HTN, cardiac failure. Headache, dizziness, leg cramps, hypoesthesia, neuralgia, paraesthesia, vertigo. GI disturbances, metabolic & nutritional disorders. Arthralgia, back pain, arthritis, arthrosis. Purpura, epistaxis, GI hemorrhage, hematoma & decreased platelet. Psychiatric & resp disorders. UTI. Cataract, conjunctivitis. Anemia.
Drug Interactions
NSAIDs, warfarin, omeprazole, esomeprazole, cimetidine, fluconazole, ketoconazole, voriconazole, etravirine, felbamate, fluoxetine, fluvoxamine & ticlopidine.
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)
ATC Classification
B01AC04 - clopidogrel ; Belongs to the class of platelet aggregation inhibitors excluding heparin. Used in the treatment of thrombosis.
Ridlor FC tab 75 mg
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in